AbbVie vs Eli Lilly: 1 Is Clearly the Better Dividend Stock to Buy and Hold for the Next 10 Years
The healthcare sector remains a top choice for dividend stocks, with AbbVie (ABBV) emerging as a standout for income-seeking investors. AbbVie boasts a forward dividend yield of 2.65%, supported by robust revenue growth from its diverse drug portfolio, including Skyrizi and Rinvoq. Recent acquisitions, like Apogee Therapeutics,...
Read More >
